SCHEMBL1572707

SCHEMBL1572707

CCCC(C)C(C)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 1/20 0.52
AKR1A1 P14550 1/20 0.52
CHRM3 P20309 1/20 0.52
HTR2A P28223 1/20 0.52
HTR2C P28335 1/20 0.52
ADRA1A P35348 1/20 0.52
HRH1 P35367 1/20 0.52
DRD3 P35462 1/20 0.52
SLC6A3 Q01959 1/20 0.52
HDAC1 Q13547 1/20 0.52
HDAC2 Q92769 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
METAP1 P53582 1/20 0.41
GRIK1 P39086 1/20 0.40
SLC1A3 P43003 1/20 0.40
SLC1A2 P43004 1/20 0.40
SLC1A1 P43005 1/20 0.40
GRIK2 Q13002 1/20 0.40
CA2 P00918 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4447254 1.00 CHRM1 (0.52) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL7803199 0.86 ACE2 (0.47) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL891187 0.85 CHRM1 (0.48) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL6250281 0.85 CA2 (0.52) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL6251102 0.85 CA2 (0.52) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL3500277 0.85 CA2 (0.52) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL10599137 0.83 CHRM1 (0.46) CHRM1AKR1A1CHRM3HTR2AHTR2C
SCHEMBL18311500 0.83 GPR84 (0.54) GRIK1SLC1A2SLC1A1GRIK2CA2
SCHEMBL544448 0.83 GPR84 (0.54) GRIK1SLC1A2SLC1A1GRIK2CA2
SCHEMBL10559661 0.83 CHRM1 (0.46) CHRM1AKR1A1CHRM3HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 289 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250320174-A1 SPIN ON METAL-ORGANIC FORMULATIONS MERCK PATENTS GMBH (DE) 2025-10-16 US claimed
CN-115874260-B Preparation method of magnesium alloy etching plate and magnesium alloy etching liquid 宝钢金属有限公司 2024-11-01 CN claimed
EP-4334252-A2 SPIN ON METAL-ORGANIC FORMULATIONS Merck Patent GmbH (DE) 2024-03-13 EP claimed
CN-117295693-A Spin-on metal-organic formulations 默克专利股份有限公司 2023-12-26 CN claimed
CN-115874260-A Preparation method of magnesium alloy etching plate and magnesium alloy etching solution 宝钢金属有限公司 2023-03-31 CN claimed
WO-2022233919-A2 SPIN ON METAL-ORGANIC FORMULATIONS MERCK PATENT GMBH (DE) 2022-11-10 WO claimed
CN-111205397-B Ionic liquid grafted cellulose nanocrystal and preparation method thereof 青岛科技大学 2022-08-23 CN claimed
CN-111205397-A Ionic liquid grafted cellulose nanocrystal and preparation method thereof 青岛科技大学 2020-05-29 CN claimed
WO-2020069214-A2 OPTIMIZED EXPRESSION SYSTEMS FOR PRODUCING CANNABINOID SYNTHASE POLYPEPTIDES, CANNABINOIDS, AND CANNABINOID DERIVATIVES DEMETRIX, INC. (US) 2020-04-02 WO claimed
CN-116659004-B Air conditioner DAIKIN INDUSTRIES, LTD. (JP) 2026-05-26 CN disclosed
EP-4743405-A1 PROCESSES FOR PRODUCING CALCIUM OXIDE AND SULFURIC ACID FROM CALCIUM SULFATE WITH MAGNESIUM INTERMEDIATE Innovator Energy Llc (US) 2026-05-20 EP disclosed
EP-4711434-A1 REFRIGERANT CYCLE APPARATUS Daikin Industries, Ltd. (JP) 2026-03-18 EP disclosed
EP-3998336-B1 MICROORGANISMS AND METHODS FOR PRODUCING CANNABINOIDS AND CANNABINOID DERIVATIVES UNIV CALIFORNIA (US) 2026-01-07 EP disclosed
EP-4234293-B1 REFRIGERATION CYCLE DEVICE FOR VEHICLE DAIKIN IND LTD (JP) 2025-12-24 EP disclosed
US-20010036916-A1 Insoluble insulin compositions BRADER MARK LAURENCE (US) 2001-11-01 US disclosed
US-6268335-B1 MICROCRYSTAL COMPRISING (A) DERIVIATED INSULIN, DERIVIATED INSULIN ANALOGS, OR DERIVIATED PROINSULINS; (B) A COMPLEXING COMPOUND; (C) A HEXAMER-STABILIZING COMPOUND; AND (D) A DIVALENT METAL CATION. ELI LILLY AND COMPANY 2001-07-31 US disclosed
WO-1999032116-A1 INSOLUBLE COMPOSITIONS FOR CONTROLLING BLOOD GLUCOSE ELI LILLY AND COMPANY (US) 1999-07-01 WO disclosed
EP-0925792-A2 Insoluble compositions for controlling blood glucose ELI LILLY AND COMPANY (US) 1999-06-30 EP disclosed
WO-1999021578-A1 INSOLUBLE INSULIN COMPOSITIONS ELI LILLY AND COMPANY (US) 1999-05-06 WO disclosed
EP-0911035-A2 INSOLUBLE INSULIN COMPOSITIONS ELI LILLY AND COMPANY (US) 1999-04-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250320174-A1 SPIN ON METAL-ORGANIC FORMULATIONS SLC39A11, SLC39A3, SLC39A7 CHRM1 776/4885AKR1A1 3908/4885CHRM3 830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.